BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14987051)

  • 1. Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer.
    Liu C; Strobl JS; Bane S; Schilling JK; McCracken M; Chatterjee SK; Rahim-Bata R; Kingston DG
    J Nat Prod; 2004 Feb; 67(2):152-9. PubMed ID: 14987051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
    Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
    Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
    J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
    Devraj R; Barrett JF; Fernandez JA; Katzenellenbogen JA; Cushman M
    J Med Chem; 1996 Aug; 39(17):3367-74. PubMed ID: 8765520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological activity of protaxols.
    Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
    Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of unique 17beta-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines.
    Bérubé G; Rabouin D; Perron V; N'Zemba B; Gaudreault RC; Parent S; Asselin E
    Steroids; 2006 Oct; 71(10):911-21. PubMed ID: 16914177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
    Rachner TD; Schoppet M; Niebergall U; Hofbauer LC
    Biochem Biophys Res Commun; 2008 Apr; 368(3):736-41. PubMed ID: 18252198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
    Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
    J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.
    Sutherland TE; Schuliga M; Harris T; Eckhardt BL; Anderson RL; Quan L; Stewart AG
    Clin Cancer Res; 2005 Mar; 11(5):1722-32. PubMed ID: 15755993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
    Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
    Burke PJ; Koch TH
    J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.